Foundations Investment Advisors LLC Has $9.08 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Foundations Investment Advisors LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 7.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 17,121 shares of the healthcare conglomerate’s stock after selling 1,382 shares during the quarter. Foundations Investment Advisors LLC’s holdings in UnitedHealth Group were worth $9,077,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in UNH. Price T Rowe Associates Inc. MD grew its holdings in shares of UnitedHealth Group by 17.8% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 36,853,394 shares of the healthcare conglomerate’s stock worth $18,929,009,000 after purchasing an additional 5,556,335 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in UnitedHealth Group by 214.1% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,648,123 shares of the healthcare conglomerate’s stock worth $832,368,000 after acquiring an additional 1,123,340 shares during the last quarter. Great West Life Assurance Co. Can bought a new stake in UnitedHealth Group during the 3rd quarter worth about $537,996,000. Finally, Jennison Associates LLC boosted its stake in shares of UnitedHealth Group by 28.3% in the 3rd quarter. Jennison Associates LLC now owns 4,752,598 shares of the healthcare conglomerate’s stock valued at $2,400,252,000 after purchasing an additional 1,047,892 shares during the last quarter. Institutional investors own 86.31% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on UNH. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $615.00 to $617.00 and gave the company a “buy” rating in a research note on Tuesday, January 24th. StockNews.com raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 11th. Stephens reiterated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research report on Tuesday, February 28th. Raymond James downgraded shares of UnitedHealth Group from a “strong-buy” rating to an “outperform” rating and set a $615.00 price target on the stock. in a research report on Monday, November 21st. Finally, Credit Suisse Group increased their price target on shares of UnitedHealth Group from $590.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, December 7th. Three equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $599.68.

UnitedHealth Group Price Performance

NYSE UNH traded down $2.52 during trading on Friday, hitting $469.50. 5,289,996 shares of the company’s stock were exchanged, compared to its average volume of 3,713,042. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.67. The company has a market cap of $437.97 billion, a PE ratio of 22.16, a P/E/G ratio of 1.30 and a beta of 0.69. UnitedHealth Group Incorporated has a fifty-two week low of $449.70 and a fifty-two week high of $558.10. The stock’s 50 day moving average price is $483.26 and its two-hundred day moving average price is $510.78.

UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 earnings per share for the quarter, topping the consensus estimate of $5.17 by $0.17. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The company had revenue of $82.79 billion for the quarter, compared to analysts’ expectations of $82.53 billion. During the same period in the previous year, the business posted $4.48 earnings per share. The business’s quarterly revenue was up 12.3% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 24.91 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 21st. Stockholders of record on Monday, March 13th will be given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date of this dividend is Friday, March 10th. UnitedHealth Group’s payout ratio is 31.15%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.